Bevacizumab plus XELOX as first-line therapy for patients with metastatic colorectal cancer

被引：0
|
作者：
Gaspar, E.
Juarez Marroqui, A.
Vicent, J.
Llorca, C.
Orts, D.
Galan, A.
Barrajon, E.
Cervera Grau, J.
Giner, V.
Macia, S.
机构：
[1] Hosp Clin Benidorm, Benidorm, Spain
[2] Hosp Gen Elda, Elda, Spain
[3] Hosp Sagunto, Sagunto, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer:The OBELIX study
    Lorenzo Antonuzzo
    Elisa Giommoni
    Davide Pastorelli
    Tiziana Latiano
    Ida Pavese
    Domenico Azzarello
    Michele Aieta
    Ilaria Pastina
    Francesca Di Fabio
    Alessandro Bertolini
    Domenico Cristiano Corsi
    Selene Mogavero
    Valentina Angelini
    Mario Pazzagli
    Francesco Di Costanzo
    [J]. World Journal of Gastroenterology, 2015, (23) : 7281 - 7288
  • [2] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [3] A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
    Yutaka Ogata
    Mototsugu Shimokawa
    Takaho Tanaka
    Yasunori Emi
    Eiji Oki
    Hiroshi Saeki
    Noriaki Sadanaga
    Tetsuya Kusumoto
    Tetsuo Touyama
    Masami Kimura
    Hideo Baba
    Yoshito Akagi
    Kazuo Shirouzu
    Yoshihiko Maehara
    [J]. International Journal of Clinical Oncology, 2016, 21 : 335 - 343
  • [4] A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
    Ogata, Yutaka
    Shimokawa, Mototsugu
    Tanaka, Takaho
    Emi, Yasunori
    Oki, Eiji
    Saeki, Hiroshi
    Sadanaga, Noriaki
    Kusumoto, Tetsuya
    Touyama, Tetsuo
    Kimura, Masami
    Baba, Hideo
    Akagi, Yoshito
    Shirouzu, Kazuo
    Maehara, Yoshihiko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 335 - 343
  • [5] Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (02) : 110 - 117
  • [6] Efficacy and tolerance of XELOX plus bevacizumab as first line therapy in Moroccan patients with metastatic colorectal cancer
    Tarik, Mahfoud
    Mohamed Reda, Khmamouche
    Rachid, Tanz
    Hassan, Errihani
    Mohamed, Ichou
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [8] A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC0902)
    Takeuchi, Masaaki
    Ogata, Yutaka
    Tanaka, Takaho
    Kaibara, Atsushi
    Emi, Yasunori
    Saeki, Hiroshi
    Oki, Eiji
    Sadanaga, Noriaki
    Kusumoto, Tetsuya
    Touyama, Tetsuo
    Matsushita, Hiroo
    Shimokawa, Mototugu
    Baba, Hideo
    Shirouzu, Kazuo
    Maehara, Yoshihiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
    Diaz-Rubio, Eduardo
    Gomez-Espana, Auxiliadora
    Massuti, Bartomeu
    Sastre, Javier
    Abad, Albert
    Valladares, Manuel
    Rivera, Fernando
    Safont, Maria J.
    Martinez de Prado, Purificacion
    Gallen, Manuel
    Gonzalez, Encarnacion
    Marcuello, Eugenio
    Benavides, Manuel
    Fernandez-Martos, Carlos
    Losa, Ferran
    Escudero, Pilar
    Arrivi, Antonio
    Cervantes, Andres
    Duenas, Rosario
    Lopez-Ladron, Amelia
    Lacasta, Adelaida
    Llanos, Marta
    Tabernero, Jose M.
    Anton, Antonio
    Aranda, Enrique
    [J]. ONCOLOGIST, 2012, 17 (01): : 15 - 25
  • [10] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer
    Doi, Toshihiko
    Boku, Narikazu
    Kato, Ken
    Komatsu, Yoshito
    Yamaguchi, Kensei
    Muro, Kei
    Hamamoto, Yasuo
    Sato, Atsushi
    Koizumi, Wasaburo
    Mizunuma, Nobuyuki
    Takiuchi, Hiroya
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 913 - 920
12345